期刊文献+

联合用药对白色念珠菌-金黄色葡萄球菌混合生物膜的作用及其影响因素 被引量:2

In vitrointeractions and infectors of drug combinations against mixed biofilm of Candida albicans and Staphylococcus aureus
原文传递
导出
摘要 目的:混合生物膜(biofilm,BF)感染发生率较前增高,联合用药是解决BF相关耐药的途径之一。通过筛选不同药物组合抗混合BF的作用,寻找有效药物组合,并探讨钙调节剂对联合用药作用的影响。方法:利用棋盘法筛选抗菌药物万古霉素、米诺环素、利福平、左氧氟沙星、磷霉素和阿奇霉素与氟康唑合用抗白色念珠菌-金黄色葡萄球菌混合BF的作用,并观察钙离子通道阻滞剂及钙离子络合剂对联合用药效果的影响。结果:米诺环素与氟康唑合用具有良好抗混合BF的作用,优于药物单用;钙离子通道阻滞剂贝尼地平、钙离子络合剂乙二胺四乙酸(EDTA)可以增强米诺环素与氟康唑联用的抗BF作用效果。结论:成熟的混合BF耐药性增强,联合用药可产生协同抗混合BF作用;扰乱细胞内钙平衡可增强抗菌作用。 OBJECTIVE Polymicrobial biofilms represent as an understudied and clinically relevant health problem, drug combination is one of the potential therapies. In order to find new therapies against mixed bioflims, the combined effects of antibacterial agents and f|uconazole (FLC) against planktonic and sessile C. albicans mixed with Staphylococcus aureus was stud- ied. And also the effects of calcium regulation agents on the combinations were explored. METHODS According to the method described in CLSI M27-A3, the microdilution method was used to investigate the combined antimicrobial effects of fluconazole with antibacterial agents(rifampin, minocycline, ofloxacin, fosfomycin, vancomycin and azithromycin)against Candida albi- cans mixed with Staphylococcus aureus both in plantonic and in biofilm. And also the effects of Ca^2+ regulations were carried by microdilution method. The results were evaluated both by visual observation and XTT (OD value) method, and two nonparametric methods (FICI and A E) were used to analyze the results. RESULTS Combined therapies of MINO and FLC had the strongest effects against mixed BF. Calcium channel blocker benidipine, EDTA could enhance the anti-BF effect of minocycline in combination with fluconazole. CONCLUSION Drug combinations had synergistic effect against mixed BF resistance. But the sentience of the bioflm was weaker when the BF was matured. Disrupting intracellular calcium balance could enhance the synergistic effect.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2014年第3期170-175,共6页 Chinese Journal of Hospital Pharmacy
基金 山东省自然基金课题(编号:ZR2011HL049 2007GG20002026)
关键词 白色念珠菌 金黄色葡萄球菌 氟康唑 混合生物膜 钙调节剂 Candida albicans Staphylococcus aureus fluconazole mixed biofilms calcium regulation
  • 相关文献

参考文献8

  • 1Donlan RM. Biofihns and device-associated infections [J]. Emerg Infect I)is,2001, 7(2) :277-281.
  • 2Morales DK, Hogan DA. Candida albicans interactions with bacteria in the context of human health and disease[J]. Plos Pathogens, 2010,6(4) :1- 4.
  • 3Tobudic S, Kratzer C, Lassnigg A, etal. Antifungal suscepti bility of Candida albicans in biofilms [J ]. Mycoses, 2012, 55 (3):199- 204.
  • 4Nobilc CJ, Fox EP, Nett JE, el al. A recently evolved tran- scriptional network controls biofilm development in Candida al-bicans[J]. Ce11,2012,148(1-2) : 126-138.
  • 5Zhang LH,Dong YH. Quorum sensing and signal interference: divelme impheations [ J ]. Mol Microbiol, 2004, 53 ( 6 ) : 1563- 1571.
  • 6Patel R. Biofilms and antimicrobial resistance[J]. Clin Orthop Relat Res,2005 Aug; (437) :41-47.
  • 7Singh R, Paul D, Jain RK. Biofilms: implications in bioreme- diation[J]. Trends Microbiol, 2006,14(9) : 389-397.
  • 8Miceli MH, Bernardo SM, Lee SA. In vitro analyses of the combination of high-dose doxycycline and antifungal agents a- gainst Candida albicans biofilms[J]. Int J Antimicrobial A- gents,2009,34(4) :326 -332.

同被引文献25

  • 1Tobudic S,Kratzer C,lassnigg A,et al.Antifungal susceptibility of Candida albicans in biofilms[J].Mycoses,2012,55 (3):199-204.
  • 2Finkel JS,Xu W,Huang D,et al.Portrait ofCandida albicans adherence regulators[J].PLoS Pathog,2012,8 (2):e1002525.
  • 3Nett J,Andes D.Candida albicans biofilm development,modeling a host-pathogen interaction[J].Curr Opin Microbiol,2006,9(4):340.
  • 4Pereira CA,Romeiro RL,Costa AC,et al.Susceptibility of Candida albicans,Staphylococcus aureus,and Streptococcus mutans biofilms to photodynamic inactivation:an in vitro study[J].Lasers Med Sci,2010,26(3):341-348.
  • 5Sardi JC,Scorzoni L,Bernardi T,et al.Candida species:current epidemiology,pathogenicity,biofilm formation,natural antifungal products and new therapeutic options[J].J Med Microbiol,2013,62(1):10-24.
  • 6Wilke MH.Treatment and prophylaxis of invasive candidiasis with anidulafungin,caspofungin and micafungin and its impact on use and costs-review of the literature[J].Eur J Med Res,2011,16(4):180-186.
  • 7Ali I,Khan FG,SuriK A,et al.In vitro antifungal activity of hydroxychavicol isolated from Piper betle L[J].Ann Clin Microbiol Antimicrob,2010,9(7):7.
  • 8Shi W,Chen Z,Chen X,et al.The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans:an in vitro interaction of antifungal and antibacterial agents[J].FEMS Yeast Res,2010,10(7):885-893.
  • 9Shinde RB,Chauhan NM,Raut JS,et al.Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A[J].Ann Clin Microbiol Antimicrob,2012,Oct 4 ; 11:27.
  • 10Rodrigues L,Banat IM,Teixeira J,et al.Biosurfactants potential applications in medicine[J].J Antimicrob Chemother,2006,57(4):609-618.

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部